NCT05813236 NOVOSYN® Quick Versus MONOSYN® Quick Suture Material in Resective Periodontal Surgery
| NCT ID | NCT05813236 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aesculap AG |
| Condition | Gingivitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 84 participants |
| Start Date | 2023-06-28 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 84 participants in total. It began in 2023-06-28 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to prove that Novosyn Quick and Monosyn Quick are equivalent in early wound healing in adult patients undergoing resective periodontal surgery. In order to show equivalence between Novosyn Quick and Monosyn Quick EHS, which is composed of 3 parameters: clinical signs of reepithelization, clinical signs of haemostasis and clinical signs of inflammation, will be calculated for each suture 10 ± 5 days postoperatively and cannot differ more than 2 points. Furthermore, complications, the handling of the suture material, pain, satisfaction of the patient and bacterial contamination of the thread (optional) will also be assessed as secondary objectives.
Eligibility Criteria
Inclusion Criteria: * Adult patient undergoing resective periodontal surgery abd one of the incisions below has been performed: * Crestal incision * Vertical incision * Intrasulcular incision * Submarginal incision * Written informed consent regarding the data collection for the RCT Exclusion Criteria: * Emergency surgery. * Pregnancy. * Breastfeeding * Patients taking medication that might affect wound healing. * Patients having a condition that might affect wound healing. * Patients with hypersensitivity or allergy to the suture material
Contact & Investigator
Carolina Mor Reinoso, Dra.
PRINCIPAL INVESTIGATOR
Facultat d'Odontologia. Universitat Internacional de Catalunya
Frequently Asked Questions
Who can join the NCT05813236 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gingivitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05813236 currently recruiting?
Yes, NCT05813236 is actively recruiting participants. Contact the research team at info@bbraun.com for enrollment information.
Where is the NCT05813236 trial being conducted?
This trial is being conducted at Sant Cugat del Vallès, Spain.
Who is sponsoring the NCT05813236 clinical trial?
NCT05813236 is sponsored by Aesculap AG. The principal investigator is Carolina Mor Reinoso, Dra. at Facultat d'Odontologia. Universitat Internacional de Catalunya. The trial plans to enroll 84 participants.